Decheng Capital Management III (Cayman)’s Pyxis Oncology PYXS Stock Holding History

Decheng Capital Management III (Cayman)’s Portfolio PYXS Stock Details PYXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$650K	Buy	+326,810	New	+$757K	0.22%	24

Other funds holding PYXS

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ECM

ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Decheng Capital Management III (Cayman)'s PYXS Position: Q3 2023 in Review

Decheng Capital Management III (Cayman) opened a new position in Pyxis Oncology (PYXS) in Q3 2023: 326,810 shares worth $650K. The stake represents 0.22% of the portfolio and ranks #24 among its holdings.

54 funds tracked by Wall St. Rank hold PYXS as of Q3 2023.

Decheng Capital Management III (Cayman) held 326,810 shares of Pyxis Oncology worth $650K as of Q3 2023.
Pyxis Oncology was a new Decheng Capital Management III (Cayman) position in Q3 2023.
Pyxis Oncology made up 0.22% of Decheng Capital Management III (Cayman)'s portfolio in Q3 2023, its #24 holding.
54 funds tracked by Wall St. Rank held Pyxis Oncology as of Q3 2023.

Based on Decheng Capital Management III (Cayman)'s 13F filing for Q3 2023, filed 13 Nov 2023.